I recently read Walter Isaacson’s biography of Steve Jobs. He
reveals in the book that when his doctors diagnosed Jobs with cancer, he paid
for an expensive and extensive analysis of his DNA to determine exactly what
type of chemotherapy would correspond precisely to the variety of cancer he
had. Until I read about this in the Jobs biography, I did not know about this dimension
of cancer treatment. Not all cancer treatment drugs are made equal. Usually
when a person receives chemo, they receive a cocktail of standard chemo drugs
that attempt to cover a wide spectrum of cancer cells. This chemo blitz is hard
on the body and is one of the reasons why people become so sick from the chemo
itself. Every person with cancer does not receive a mix of chemo/drugs tailored
to his or her unique body and specific cancer because it costs a fortune to pay
for the research to identify which chemo/drug to use, based on the person’s
DNA.
I recently read an article about genetic researchers in St. Louis
who made a commitment to attempt to identify the gene that was causing one of
their own to suffer from lymphoblastic leukemia. A beloved colleague, a young
doctor who had been working on the genetic research project, was diagnosed with
lymphoblastic leukemia and the rest of the team determinedly set out to
investigate the complete genetic makeup of him and his cancer. They fully
sequenced the genes of both his cancer cells and his healthy cells for
comparison. They also analyzed his RNA. They set aside their work on the human
genome (the research project they had all been working on) and they ran a
sequencing machine and a supercomputer 24/7 for six months. They found the
rogue gene causing the doctor’s cancer; a gene that had gone haywire and was
manufacturing large amounts of a protein that was feeding the cancer’s growth. So
they treated the doctor with a selected drug that was highly likely to shut
down the malfunctioning of this particular rogue gene. And it worked and now
the doctor’s cancer is in remission.
I certainly rejoice that a man’s life was saved, but I also feel enraged.
Even though the genetic analysis and tailored chemo program that Jobs bought
did not save his life, it was more likely to have done so than any other
approach. Also, the chemo Jobs underwent was the easiest on his system of any
treatment he could have received because it was exactly matched to his cancer
and not just a wash of chemo products thrown at the disease. The young doctor
benefitted from the same type of research and the same treatment approach. It
angers me that every single person who contracts cancer cannot access this state-of-the-art
treatment that Jobs received, or that the young doctor in St. Louis received.
Why? Only because it costs too much money. And so now we get down to it. The
value of human life.
Medical researchers have confirmed that it is not the person’s
tissue or organ (i.e., liver, brain, bone marrow, blood, intestine) where the
cancer originates that drives a cancer but rather the person’s genes. Cancer
treatment is most effective when it is tailored to the exact aberrant genes
causing the disease. Thus, one woman’s breast cancer may have completely
different genetic drivers from another woman’s breast cancer, and each needs to
be treated with a completely different chemo/drug. This method of figuring out
precisely which genes have gone whack and treating cancer based on that
analysis is called “whole genome sequencing,” and it is presently not available
to the everyday Joe. It is also not paid for by any insurance company. Only
someone as wealthy (and well-connected) as Jobs could afford to pay for whole
genome sequencing. Isaacson disclosed that it cost Jobs $100,000 for the
sequencing and analysis of his genes to isolate those causing his cancer.
Medical researchers speculate that it will take at least another
ten years before whole genome sequencing will be made available to most
patients rather than just the wealthy few. When do you reckon that insurance
companies will agree to pay for this at $100,000 a pop? Makes me wanna holler.
No comments:
Post a Comment